Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, announced the conclusion of its strategic review process, which included evaluating a range of strategic alternatives such as a sale, merger, or other transaction. The Board, with assistance from Goldman Sachs and Sidley Austin, decided that continuing as an independent, public company aligns best with shareholder interests. Despite serious interest from various parties, no formal proposals were received, attributed to macro headwinds like uncertain regulatory developments, a challenging healthcare environment, and high interest rates. The company plans to focus on its core business, having seen positive momentum into 2024 with new hires, improved payor contracts, and controlled expenses.